No known molecular target

The term "No known molecular target" is used as a placeholder in scientific literature or drug databases to indicate that a compound, drug, or biological effect does not have a precisely identified interacting molecule or biological macromolecule. It implies that the underlying mechanism, associated protein, enzyme, transporter, receptor, or other target is not yet annotated or understood at the molecular level. Drugs or compounds with "no known molecular target" are those whose effects and therapeutic actions have been observed, but whose interactions are not mapped to specific molecular entities. This designation commonly appears in contexts where phenotypic drug screening is performed or in the early phases of biomedical research prior to molecular target deconvolution[1][4][5]. The phrase itself is not suitable as a molecular target or biomarker and should not be used for structured molecular biology or pharmacology data extraction. It is essentially a note on incomplete knowledge or missing data, rather than a biological classifier or targetable entity[3][4][5].

Other names

No known molecular targetUnknown molecular targetUndetermined target